 |
|
| Blog results | Results 1 - 10 of about 28,852 for non small cell lung cancer treatment. (0.16 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Lung cancer blog: From MedicineWorld.Org - http://medicineworld.org/cancer/lung/lung-cancer-blog.html Cancer Resources from OncoLink | Treatment, Research, Coping ... - http://www.oncolink.org/index.cfm Lung cancer - http://lungcancertreatmenttips.blogspot.com/ The Best Lung Cancer Information - http://lungcancer-pedia.blogspot.com/ Kevin Brumett @ Breath of Hope - http://breathofhope.net/ | |
| 16 Dec 2009 by Ani December 8th, 2009 more images more images Bryant Gumbel says he has lung cancer NEW YORK — Bryant Gumbel shocked a television audience with the news that he's recovering from lung cancer surgery and treatment. ... The study showed that patients with advanced non-small cell lung cancer who are given cetuximab (Erbitux) in addition to chemotherapy are 13pct less likely to die than those who receive chemotherapy alone, regardless of which chemotherapy drug cocktail is used. ... Health News - http://blog.taragana.com/health/ [ More results from Health News ] |
| 17 Dec 2009 by Business Wire The open-label, multi-center Phase 2 study is designed to evaluate the efficacy and safety of STA-9090 in patients with stage IIIB or IV non-small cell lung cancer who have received prior treatment with either an approved tyrosine ... Your Story - http://www.your-story.org/ [ More results from Your Story ] |
| 8 Dec 2009 NCCN updates the NCCN Guidelines for Non-Small Cell Lung Cancer to include guidance on maintenance therapy, several new therapeutic recommendations for specific patients with Non-Small Cell Lung Cancer, and a revised staging system. ... Staging provides the basis for evaluating a patient's prognosis and is a valuable aid in the treatment selection of patients with lung cancer. The revised system more accurately reflects a patient's prognosis and current practice. ... National Comprehensive Cancer Network - http://www.nccn.org/ [ More results from National Comprehensive Cancer Network ] |
| 17 Dec 2009 Paclitaxel and Carboplatin alone for the treatment of advanced non-small cell lung cancer is being conducted under the FDA's Special Protocol Assessment. It blinds Novelos from seeing any results as it progresses. ... BAYSTREET NEWSWIRE - http://www.baystreet.ca/newswire/ |
| 17 Dec 2009 LUX-Lung 1 investigates BIBW 2992 (planned brand name Tovok™) plus best supportive care (BSC) versus placebo plus BSC in non-small cell lung cancer patients who have experienced a failure of treatment with erlotinib or gefitinib (EGFR ... Pharmacy Europe - http://www.pharmacyeurope.net/rss.asp |
| 11 Dec 2009 by admin The type of treatment or combination of treatments used depends on the type and stage of cancer. Non-small cell lung cancer differs from person to person. There is no easy way to pre-determine how an individual patient will respond to ... Lung Cancer - http://lung-cancer-stage.blogspot.com/ |
| 9 hours ago by frontierlifeline NON-SMALL CELL LUNG CARCINOMA (NSCLC). Frequent and Highly aggressive. Occurs largely in smokers. It grows rapidly and majority of the patients have widespread metastatic disease at the time of diagnosis. SMALL CELL LUNG CARCINOMA (SCLC) ... Smoking is the most important contributory factor in the causation of lung cancer52. In patients with lung cancer a history of active tobacco smoking is present in 87% of males and in 85% of females. History of passive tobacco ... Frontier Lifeline - http://frontierlifeline.wordpress.com/ |
| 17 Dec 2009 by DoctorFrog FDA Advisory Committee Recommends Against Approving Tarceva For First-Line Maintenance Use In Advanced Non-Small Cell Lung Cancer. OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) and Genentech, Inc., a wholly owned member of the Roche Group (SIX: ... (erlotinib) for first-line maintenance use in people with advanced or metastatic non-small cell lung cancer (NSCLC) whose cancer has not progressed (grown or spread) following first-line treatment with platinum-based chemotherapy… ... Procto-Med - http://www.procto-med.com/ [ More results from Procto-Med ] |
| 2 Dec 2009 EGFR is found on the surface of many types of cancer cells, including non-small cell lung cancer (NSCLC). Erlotinib is approved by the Food and Drug Administration (FDA) for the treatment of NSCLC. Hydroxychloroquine (HCQ) is a drug ... Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
| 29 Oct 2009 by Socinski, Langer, Huang, Kolb, Compton,... Purpose Patients with non–small-cell lung cancer (NSCLC) and brain metastases have previously been excluded from trials of bevacizumab because of suspected risk of CNS hemorrhage. ... Patients and Methods This open-label multicenter trial for first- and second-line treatment of nonsquamous NSCLC enrolled patients with treated brain metastases. First-line patients received bevacizumab (15 mg/kg) every 3 weeks with platinum-based doublet therapy or erlotinib (at physician's ... Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/ [ More results from Journal of Clinical Oncology Current Issue ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
